drugset / Trial / NCT00114062

Study to Treat Uveitis Associated Macular Edema

NCT00114062 ↗

Phase 2 Terminated 15 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether denufosol tetrasodium (INS37217) Intravitreal Injection is well tolerated and has the potential to treat uveitis associated macular edema.

Timeline

Start
2005-09
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject denufosol Other / unclassified — Intravitreal